Ano Kaisha no Shikumi
Search
Menu

MIZUHO MEDY

MIZUHO MEDY CO.,LTD.

Company highlights

The largest holder on the register is 唐川 文成, at 20.5%.

Key figures

Period Jan 2025 to Dec 2025Parent onlyJapanese GAAP

RevenueDisclosed ¥11.3B
Operating marginCalculated 41.3%
Net assets to total assetsCalculated 83.5%

Company profile

Securities code 4595 / EDINET code E31946 / Pharmaceuticals / Fiscal year end December 31

鳥栖市藤木町５番地の４／Capital stock ¥464 million
Address, capital stock, fiscal year end and industry: the FSA’s EDINET code list.

Company details
唐川 文成 Representative

Tables scroll sideways

Disclosed data

Source: Annual Securities Report (Jan 2025 to Dec 2025) · filed 2026-03-26

Profitability ★★★★★position among all companies 41.3%
Growth (revenue, 4-year average) ★☆☆☆☆position among all companies -3.8%
Capital efficiency ★★★★★position among all companies 19.0%

Business activities and revenue composition

Revenue and profit by business segment

Disclosed segments (business divisions used in reporting): one

Revenue and profit

Amounts by account
GroupAccountAmountConsolidated / Non-consolidated
Selling, general and administrative expenses Salaries, allowances and bonuses ¥0.8 billion Parent only
Research and development expenses ¥0.8 billion Parent only
Other ¥0.7 billion Parent only
Commission fees ¥0.3 billion Parent only
Welfare expenses ¥0.1 billion Parent only
Directors' compensations ¥0.1 billion Parent only
Provision for directors' retirement benefits ¥79.00 million Parent only
Traveling and transportation expenses ¥71.00 million Parent only
Depreciation ¥42.00 million Parent only
Provision for bonuses ¥37.00 million Parent only
Retirement benefit expenses ¥24.00 million Parent only
Provision of allowance for doubtful accounts ¥0 Parent only
Profit by stage Gross profit (loss) ¥7.8 billion Parent only
Ordinary income ¥4.7 billion Parent only
Operating income ¥4.6 billion Parent only

MIZUHO MEDY

Selling, general and administrative expenses

Period Jan 2025 to Dec 2025Source Annual securities reports

Salaries, allowances and bonuses ¥0.8 billion (28.9%)29%Research and development expenses ¥0.8 billion (28.1%)28%Other ¥0.7 billion (23.2%)23%Commission fees ¥0.3 billion (10.7%)11%Welfare expenses ¥0.1 billion (4.9%)Directors' compensations ¥0.1 billion (4.2%)¥2.9B
  • Salaries, allowances and bonuses　¥0.8 billion
  • Research and development expenses　¥0.8 billion
  • Other　¥0.7 billion
  • Commission fees　¥0.3 billion
  • Welfare expenses　¥0.1 billion
  • Directors' compensations　¥0.1 billion

Performance, financial position and capital allocation

Finance
83.5% Net assets to total assets Industry median 69.7% FY ending 12/2025 · consolidated / calculated
¥980.89 Net assets per share
¥22.4 billion Total assets
Capital allocation
42.1% Cash conversion Industry median 112.1% FY ending 12/2025 · consolidated / calculated

Long-term changes in performance

Period 2012 to 2025Disclosed

Revenue ×3.54 from 2012 to 2025

MIZUHO MEDY

Long-term revenue, profit and asset trends

Period 2012 to 2025Source Annual securities reportsDisclosed

Mark on the chart
18 12 6 0 2012 2014 2016 2018 2020 2022 2024 2025 Net sales and operating revenue Ordinary income 2014　Net sales year on year +22.7%, Ordinary income (loss) as a share of revenue +5.5 points 2015　Ordinary income (loss) as a share of revenue -2.4 points 2016　Net sales year on year +21.5% 2017　Ordinary income (loss) as a share of revenue +4.6 points 2018　Ordinary income (loss) as a share of revenue +3.7 points 2020　Net sales year on year -34.6%, Ordinary income (loss) as a share of revenue -7.4 points 2021　Net sales year on year +212.4%, Ordinary income (loss) as a share of revenue +41.1 points 2022　Net sales year on year +33.8%, Ordinary income (loss) as a share of revenue +12.0 points 2023　Net sales year on year -37.5%, Ordinary income (loss) as a share of revenue -14.8 points 2024　Ordinary income (loss) as a share of revenue -2.9 points 2025　Ordinary income (loss) as a share of revenue -3.1 points 11Latest value 2025 11¥ billion 18Highest in the period shown 2022 18¥ billion 3Lowest in the period shown 2012 3¥ billion ¥ billion

MIZUHO MEDY

Recent performance trends

Source Annual securities reports

18 12 6 0 4 years ago 3 years ago 2 years ago Last year This year Net sales and operating revenue Ordinary income ¥ billion

Year-on-year comparison

Period 2012 to 2025Disclosed

Item20212022202320242025
Net sales ¥13.1B ¥17.6B ¥11.0B ¥11.4B ¥11.3B
Year on year (%) +212.4%◆ +33.8%◆ -37.5%◆ +4.0% -1.5%
Ordinary income (loss) ¥6.7B ¥11.1B ¥5.3B ¥5.2B ¥4.7B
Change from prior year +1,513.8% +65.2% -52.2% -2.4% -8.3%
Ordinary income (loss) as a share of Net sales 51.0% 63.0% 48.2% 45.2% 42.1%
Change (percentage points) +41.1 points◆ +12.0 points◆ -14.8 points◆ -2.9 points◆ -3.1 points◆

Fiscal periods marked for changes

Earlier fiscal periods (8)
  • 2014Net sales year on year +22.7%, Ordinary income (loss) as a share of revenue +5.5 points
  • 2015Ordinary income (loss) as a share of revenue -2.4 points
  • 2016Net sales year on year +21.5%
  • 2017Ordinary income (loss) as a share of revenue +4.6 points
  • 2018Ordinary income (loss) as a share of revenue +3.7 points
  • 2020Net sales year on year -34.6%, Ordinary income (loss) as a share of revenue -7.4 points
  • 2021Net sales year on year +212.4%, Ordinary income (loss) as a share of revenue +41.1 points
  • 2022Net sales year on year +33.8%, Ordinary income (loss) as a share of revenue +12.0 points
  • 2023Net sales year on year -37.5%, Ordinary income (loss) as a share of revenue -14.8 points
  • 2024Ordinary income (loss) as a share of revenue -2.9 points
  • 2025Ordinary income (loss) as a share of revenue -3.1 points

MIZUHO MEDY

Earnings and net assets per share over time

Unit yenSource Annual securities reports

411 274 137 0 4 years ago 3 years ago 2 years ago Last year This year Earnings per share yen 981 654 327 0 4 years ago 3 years ago 2 years ago Last year This year Net assets per share yen

MIZUHO MEDY

Return on equity over time

Unit %Source Annual securities reports

82 54 27 0 4 years ago 3 years ago 2 years ago Last year This year Return on equity (ROE, %)
Parent only indicators (18 items)
Item4 years ago3 years ago2 years agoLast yearThis year
Net sales ¥13.1 billion ¥17.6 billion ¥11.0 billion ¥11.4 billion ¥11.3 billion
Ordinary income (loss) ¥6.7 billion ¥11.1 billion ¥5.3 billion ¥5.2 billion ¥4.7 billion
Net income (loss) ¥4.8 billion ¥7.8 billion ¥3.8 billion ¥3.8 billion ¥3.4 billion
Capital stock ¥0.5 billion ¥0.5 billion ¥0.5 billion ¥0.5 billion ¥0.5 billion
Total number of issued shares (common stock) 9,525,000 shares 9,525,000 shares 9,525,000 shares 19,051,000 shares 19,051,000 shares
Net assets ¥8.0 billion ¥14.3 billion ¥15.7 billion ¥17.4 billion ¥18.7 billion
Total assets ¥12.2 billion ¥19.1 billion ¥18.9 billion ¥20.7 billion ¥22.4 billion
Net assets per share 421.47 yen 749.79 yen 822.93 yen 911.05 yen 980.89 yen
Dividend per share 155 yen 250 yen 200 yen 140 yen 100 yen
Interim dividend per share 50 yen 60 yen 60 yen 80 yen 50 yen
Basic earnings (loss) per share 252.86 yen 411.47 yen 198.13 yen 198.12 yen 179.84 yen
Equity-to-asset ratio 65.8% 74.8% 82.7% 83.7% 83.5%
Return on equity 81.6% 70.3% 25.2% 22.9% 19.0%
Payout ratio 30.6% 30.4% 50.5% 50.5% 55.6%
Net cash provided by (used in) operating activities ¥5.6 billion ¥6.2 billion ¥4.0 billion ¥3.3 billion ¥2.0 billion
Net cash provided by (used in) investing activities ¥-0.2 billion ¥-1.6 billion ¥-0.3 billion ¥-0.3 billion ¥-7.3 billion
Net cash provided by (used in) financing activities ¥-1.2 billion ¥-1.6 billion ¥-2.4 billion ¥-2.1 billion ¥-2.1 billion
Cash and cash equivalents ¥4.3 billion ¥7.4 billion ¥8.7 billion ¥9.7 billion ¥2.3 billion

Dividend history

Source: reporting company’s key figures, annual securities reports · 14 years (2012 to 2025)Parent-onlyDisclosed

0 periods Consecutive increases (own definition) through FY ending 12/2025
1 periods Consecutive periods with dividends (site definition) through FY ending 12/2025
No comparison with the previous year Dividend growth (year on year)
Fewer than six years Dividend growth (5-year annual rate)
Fiscal yearAnnual dividend per share Of which interimPayout ratio (as reported, parent only) Flag
FY ending 12/2025 ¥100 ¥50 55.6%
FY ending 12/2024 ¥140 ¥80 50.5% Stock split or share consolidation noted
FY ending 12/2023 ¥200 ¥60 50.5%
FY ending 12/2022 ¥250 ¥60 30.4%
FY ending 12/2021 ¥155 ¥50 30.6%
FY ending 12/2020 ¥10 Could not be retrieved 31.1%
FY ending 12/2019 ¥29 Could not be retrieved 31.6%
FY ending 12/2018 ¥29 Could not be retrieved 30.0% Stock split or share consolidation noted
FY ending 12/2017 ¥42 Could not be retrieved 30.3% Stock split or share consolidation noted
FY ending 12/2016 ¥50 Could not be retrieved 30.1%
FY ending 12/2015 ¥37 Could not be retrieved 30.5% Stock split or share consolidation noted
FY ending 12/2014 ¥230 Could not be retrieved 30.7%
FY ending 12/2013 ¥100 Could not be retrieved 30.4%
FY ending 12/2012 ¥80 Could not be retrieved 39.2%

MIZUHO MEDY

Dividends per share over time

Unit yenSource Annual securities reports

250 167 83 0 4 years ago 3 years ago 2 years ago Last year This year Dividend per share yen

Shareholder composition

As of 2025-12-31Disclosed

Share ownership by holder category

18,467 Shareholders
7.33% Foreign holders (total) Industry median 9.03%
84.03% Individuals and others Industry median 55.96%

MIZUHO MEDY

Unit %Source Annual securities reports

  • Financial institutions2.71%
  • Securities firms4.99%
  • Other corporations0.94%
  • Foreign holders (institutions)7.27%
  • Foreign holders (individuals)0.06%
  • Individuals and others84.03%

Major shareholders

RankShareholderShareholding ratioShares held
1 唐川 文成 20.54% 3,914,000
2 ミズホメディー社員持株会 2.23% 426,000
3 株式会社西日本シティ銀行 2.09% 400,000
4 三菱UFJeスマート証券株式会社 1.62% 309,000
5 BNY GCM CLIENT ACCOUNT JPRD AC ISG (FE-AC)（常任代理人 株式会社三菱UFJ銀行） 1.35% 257,000
6 BNYM SA/NV FOR BNYM FOR BNY GCM CLIENT ACCOUNTS M LSCB RD（常任代理人 株式会社三菱UFJ銀行） 1.27% 243,000
7 モルガン・スタンレーMUFG証券株式会社 1.17% 224,000
8 山口 和也 1.11% 212,000
9 村田 淳一 1.09% 208,000
10 唐川 則康 1.04% 200,000

Research and development expenses and capital expenditure

Source: R&D and capital expenditure sections, annual securities reports · 2 years (2020 to 2025)Disclosed

¥0.8 billion Research and development
¥0.3 billion Capital expenditure
Fiscal year Research and development Capital expenditure
FY ending 12/2025 ¥0.8 billion ¥0.3 billion
FY ending 12/2020 ¥0.5 billion ¥0.1 billion

Revenue scale in the same industry

MIZUHO MEDY

Source Annual securities reports of each company

Pharmaceuticals: 68 companies · revenue · largest first・each company’s latest fiscal year・consolidated (parent-only where no consolidated figures)・Disclosed

Workforce information

Source: Annual Securities Report (Jan 2025 to Dec 2025)Parent-onlyDisclosed

193 Employees (parent only) Industry median 94
43.2 Average age Industry median 44.3
11.0 years Average length of service Industry median 9.6 years
¥7.90 million Average annual salary Industry median ¥8.24 million
People and organisation
58.3¥ million Sales per employee Industry median 38.4¥ million FY ending 12/2025 · parent company only / calculated
¥24.07 million Operating income per employee
57.2% Wage gap between men and women
20.8% Women in managerial positions
50 Average temporary staff

Administrative filings and published information

Workplace information filings

Filed 2026-06-25Disclosed

ItemValue
Employees 245
Share of managers who are women 20.8%

Subsidy award information

1 awards, 2020-11-09 to 2020-11-09Disclosed

Date approvedSubsidyMinistryAmount
2020-11-09感染症対策関連物資生産設備補助事業（感染症検査キット等生産設備補助）経済産業省 ¥78.85 million

Audit and disclosure information

Annual securities report, year ended 2025-12-31Disclosed

ItemValue
Audit firm 有限責任監査法人トーマツ
Audit fees (this year, filing company) ¥21.00 million
Non-audit fees (this year, filing company) ¥1.00 million
Going concern note Cannot be determined
Accounting standard Japanese GAAP

See the book series →

Sources and methodology

Retrieved disclosed figures

Accounts and values from the annual securities report, by section

Major management indicators (5 years) (18 items)

ItemValueConsolidated / Non-consolidated
Dividend per share 100 yen Parent only
Net cash provided by (used in) operating activities ¥2.0 billion Parent only
Net sales ¥11.3 billion Parent only
Net income (loss) ¥3.4 billion Parent only
Net cash provided by (used in) investing activities ¥-7.3 billion Parent only
Cash and cash equivalents ¥2.3 billion Parent only
Total number of issued shares (common stock) 19,051,000 shares Parent only
Net assets ¥18.7 billion Parent only
Ordinary income (loss) ¥4.7 billion Parent only
Total assets ¥22.4 billion Parent only
Return on equity 19.0% Parent only
Equity-to-asset ratio 83.5% Parent only
Net cash provided by (used in) financing activities ¥-2.1 billion Parent only
Capital stock ¥0.5 billion Parent only
Payout ratio 55.6% Parent only
Interim dividend per share 50 yen Parent only
Basic earnings (loss) per share 179.84 yen Parent only
Net assets per share 980.89 yen Parent only

Employees (8 items)

ItemValueConsolidated / Non-consolidated
Wage gap between men and women (all employees) 57.2% Parent only
Average length of service (years) 11 years Parent only
Average annual salary ¥7.90 million Parent only
Average age (years) 43.2 years old Parent only
Number of employees 193 people Parent only
Number of employees 193 people Parent only
Wage gap between men and women (regular employees) 81.2% Parent only
Wage gap between men and women (non-regular employees) 61.8% Parent only

Other disclosed items (5 items)

ItemValueConsolidated / Non-consolidated
Rate of male employees taking childcare leave (all employees) 0.0% Parent only
Average number of temporary employees 50 people Parent only
Average number of temporary employees 50 people Parent only
Total return on the share price index 213.2% Parent only
Ratio of female employees in managerial positions 20.8% Parent only

Shares (12 items)

ItemValueConsolidated / Non-consolidated
Number of shares held 6,395,000 shares Consolidated
Total number of shares held treasury shares etc 2,500 shares Consolidated
Number of shares 19,051,200 shares Consolidated
Shareholding ratio treasury shares etc 0.0% Consolidated
Shareholding ratio 33.6% Consolidated
Number of shares held in own name treasury shares etc 2,500 shares Consolidated
Number of voting rights 189,987 units Consolidated
Carrying amount on the balance sheet ¥2.00 million Consolidated
Carrying amount on the balance sheet ¥1.00 million Consolidated
Number of issues 3 issues Consolidated
Number of issues 1 issues Consolidated
Total shareholder return 343.3% Parent only

Research and development (1 items)

ItemValueConsolidated / Non-consolidated
Research and development expenses ¥0.8 billion Consolidated

Property and facilities (1 items)

ItemValueConsolidated / Non-consolidated
Capital expenditures ¥0.3 billion Consolidated

Audit (3 items)

ItemValueConsolidated / Non-consolidated
Fees for audit and attestation services - reporting company ¥21.00 million Consolidated
Fees for non-audit services - reporting company ¥0 Consolidated
Fees for non-audit services - reporting company ¥1.00 million Consolidated

Balance sheet (58 items)

ItemValueConsolidated / Non-consolidated
Other ¥7.00 million Parent only
Other ¥96.00 million Parent only
Other ¥0.1 billion Parent only
Other ¥34.00 million Parent only
Valuation difference on available-for-sale securities ¥0 Parent only
Software ¥1.00 million Parent only
Work in process ¥0.6 billion Parent only
General reserve ¥0.2 billion Parent only
Retained earnings ¥17.9 billion Parent only
Legal retained earnings ¥31.00 million Parent only
Raw materials ¥0.8 billion Parent only
Merchandise and finished goods ¥1.0 billion Parent only
Non-current liabilities ¥1.0 billion Parent only
Non-current assets ¥2.8 billion Parent only
Land ¥0.7 billion Parent only
Accounts receivable - trade ¥5.5 billion Parent only
Contract liabilities ¥5.00 million Parent only
Tools, furniture and fixtures ¥0.2 billion Parent only
Buildings, net ¥0.7 billion Parent only
Construction in progress ¥3.00 million Parent only
Provision for directors' retirement benefits ¥0.8 billion Parent only
Investments and other assets ¥0.5 billion Parent only
Investment securities ¥3.00 million Parent only
Property, plant and equipment ¥2.3 billion Parent only
Income taxes payable ¥1.1 billion Parent only
Accrued consumption taxes ¥0.4 billion Parent only
Accrued expenses ¥74.00 million Parent only
Accounts payable - other ¥0.3 billion Parent only
Shareholders' equity ¥18.7 billion Parent only
Structures, net ¥33.00 million Parent only
Machinery and equipment, net ¥0.6 billion Parent only
Current liabilities ¥2.7 billion Parent only
Current assets ¥19.6 billion Parent only
Accumulated depreciation ¥-2.3 billion Parent only
Intangible assets ¥36.00 million Parent only
Cash and cash equivalents ¥2.3 billion Parent only
Cash and deposits ¥10.8 billion Parent only
Net assets ¥18.7 billion Parent only
Net assets ¥18.7 billion Parent only
Total assets ¥22.4 billion Parent only
Deferred tax assets ¥0.5 billion Parent only
Retained earnings brought forward ¥17.7 billion Parent only
Treasury stock ¥-2.00 million Parent only
Valuation and translation adjustments ¥0 Parent only
Liabilities ¥3.7 billion Parent only
Liabilities and net assets ¥22.4 billion Parent only
Accounts payable - trade ¥0.3 billion Parent only
Allowance for doubtful accounts ¥-2.00 million Parent only
Capital surplus ¥0.3 billion Parent only
Legal capital surplus ¥0.3 billion Parent only
Capital stock ¥0.5 billion Parent only
Provision for bonuses ¥67.00 million Parent only
Provision for retirement benefits ¥0.2 billion Parent only
Long-term prepaid expenses ¥10.00 million Parent only
Shares of subsidiaries and associates ¥0 Parent only
Electronically recorded obligations - operating ¥0.2 billion Parent only
Electronically recorded monetary claims - operating ¥0.7 billion Parent only
Deposits received ¥0.1 billion Parent only

Statement of income (48 items)

ItemValueConsolidated / Non-consolidated
Other ¥2.00 million Parent only
Other ¥0.7 billion Parent only
Transfer from other account cos ¥14.00 million Parent only
Transfer to other accounts ¥0.2 billion Parent only
Dividends from surplus ¥-2.1 billion Parent only
Interest and dividend income ¥0.1 billion Parent only
Guaranty money income ¥2.00 million Parent only
Total ¥4.5 billion Parent only
Cost of merchandise and finished goods sold ¥3.4 billion Parent only
Ending merchandise and finished goods ¥1.0 billion Parent only
Beginning merchandise and finished goods ¥0.6 billion Parent only
Operating income ¥4.6 billion Parent only
Non-operating income ¥0.1 billion Parent only
Non-operating expenses ¥18.00 million Parent only
Net cash provided by (used in) operating activities ¥2.0 billion Parent only
Gross profit (loss) ¥7.8 billion Parent only
Net sales ¥11.3 billion Parent only
Cost of purchased goods ¥0.2 billion Parent only
Net income (loss) ¥3.4 billion Parent only
Net income (loss) ¥3.4 billion Parent only
Cost of products manufactured ¥3.7 billion Parent only
Directors' compensations ¥0.1 billion Parent only
Provision for directors' retirement benefits ¥79.00 million Parent only
Loss on valuation of investment securities ¥4.00 million Parent only
Net cash provided by (used in) investing activities ¥-7.3 billion Parent only
Commission fees ¥0.3 billion Parent only
Traveling and transportation expenses ¥71.00 million Parent only
Income taxes - current ¥1.4 billion Parent only
Income taxes ¥1.3 billion Parent only
Income taxes - deferred ¥-52.00 million Parent only
Depreciation ¥42.00 million Parent only
Foreign exchange losses ¥13.00 million Parent only
Effect of exchange rate change on cash and cash equivalents ¥0 Parent only
Net increase (decrease) in cash and cash equivalents ¥-7.4 billion Parent only
Research and development expenses ¥0.8 billion Parent only
Research and development expenses ¥0.8 billion Parent only
Welfare expenses ¥0.1 billion Parent only
Income (loss) before income taxes ¥4.7 billion Parent only
Income (loss) before income taxes ¥4.7 billion Parent only
Ordinary income ¥4.7 billion Parent only
Salaries, allowances and bonuses ¥0.8 billion Parent only
Purchase of treasury stock ¥-0 Parent only
Subsidy income ¥2.00 million Parent only
Net cash provided by (used in) financing activities ¥-2.1 billion Parent only
Selling, general and administrative expenses ¥3.2 billion Parent only
Provision of allowance for doubtful accounts ¥0 Parent only
Provision for bonuses ¥37.00 million Parent only
Retirement benefit expenses ¥24.00 million Parent only

Accounts unique to this company (2 items)

ItemValueConsolidated / Non-consolidated
Revenue ¥46.00 million Parent only
Revenue ¥0.2 billion Parent only

Statement of changes in equity (2 items)

ItemValueConsolidated / Non-consolidated
Total changes during the period ¥1.3 billion Parent only
Net changes in items other than shareholders' equity ¥0 Parent only

Statement of cash flows (25 items)

ItemValueConsolidated / Non-consolidated
Other ¥68.00 million Parent only
Other ¥-0 Parent only
Increase decrease in notes and accounts payable trade ¥-36.00 million Parent only
Interest and dividends income received ¥83.00 million Parent only
Interest and dividend income ¥-0.1 billion Parent only
Decrease increase in notes and accounts receivable trade ¥-1.7 billion Parent only
Proceeds from withdrawal of time deposits ¥3.0 billion Parent only
Payments into time deposits ¥-10.0 billion Parent only
Subtotal ¥3.0 billion Parent only
Increase decrease in provision for directors retirement benefits ¥-18.00 million Parent only
Purchase of property plant and equipment ¥-0.3 billion Parent only
Increase decrease in income taxes payable the factor based tax ¥8.00 million Parent only
Decrease in consumption taxes payable ¥0.2 billion Parent only
Decrease (increase) in inventories ¥-0.4 billion Parent only
Income taxes paid ¥-1.2 billion Parent only
Depreciation ¥0.3 billion Parent only
Foreign exchange loss (gain) ¥15.00 million Parent only
Purchase of intangible assets ¥-28.00 million Parent only
Regarding purchase of treasury stock ¥-0 Parent only
Proceeds from subsidy income ¥2.00 million Parent only
Subsidy income ¥-2.00 million Parent only
Increase (decrease) in allowance for doubtful accounts ¥0 Parent only
Increase (decrease) in provision for bonuses ¥-15.00 million Parent only
Accrued pension cost ¥-40.00 million Parent only
Dividends ¥-2.1 billion Parent only
Basic indicators
ItemValueConsolidated / Non-consolidatedSource
Net cash provided by (used in) operating activities ¥2.0 billion Parent onlyDisclosed
Dividend per share 100 Parent onlyDisclosed
Number of employees 193 Parent onlyDisclosed
Net assets ¥18.7 billion Parent onlyDisclosed
Net sales ¥11.3 billion Parent onlyDisclosed
Operating income ¥4.6 billion Parent onlyDisclosed
Ordinary income ¥4.7 billion Parent onlyDisclosed
Total assets ¥22.4 billion Parent onlyDisclosed
Operating margin 41.3%Parent onlyCalculated
Net margin Not disclosedNot applicableNot calculated (a required value is not disclosed)
Sales per employee 58341969 yenParent onlyCalculated
Total asset turnover 0.5 timesParent onlyCalculated
Net assets to total assets 83.5%Parent onlyCalculated
How to read the figures, and caveats

Terms

  • Consolidated: the parent company together with the subsidiaries it consolidates
  • Parent-only: the single company that filed the annual securities report
  • Calculated: a disclosed figure put through the formula shown
  • Not disclosed: no such value in the filing (not treated as zero)
  • Not retrieved: a value this page could not extract, including values in the filing that could not be matched. The same item may appear in another table
  • Segment: a business division the company uses in its disclosures
  • Industry median: the middle value among companies in the same industry that disclose the item
  • ★: position when every company is lined up by value (not a judgement of the company)See the formulas
  • Source: document name, period covered, filing date and where it was obtained
  • Tables scroll sideways

Key figures

  • Operating margin 41.3%　Operating income ÷ net sales 　＝ ¥4.6 billion ÷ ¥11.3 billion
    Operating income ÷ net sales. The denominator is Net sales (Parent only, Japanese GAAP).
  • Sales per employee 58,341,969 yen　Sales or operating revenue ÷ employees 　＝ ¥11.3 billion ÷ 193 people
    Sales or operating revenue ÷ employees. The denominator is Number of employees (Parent only, Japanese GAAP).
  • Total asset turnover 0.5 times　Sales or operating revenue ÷ total assets 　＝ ¥11.3 billion ÷ ¥22.4 billion
    Sales or operating revenue ÷ total assets. The denominator is Total assets (Parent only, Japanese GAAP).
  • Net assets to total assets 83.5%　Net assets ÷ total assets 　＝ ¥18.7 billion ÷ ¥22.4 billion
    Net assets ÷ total assets. The denominator is Total assets (Parent only, Japanese GAAP).

Company details

  • Representative　Chairman and President, Representative Director, gBizINFO

Amounts by account

  • Totals and their component lines together; consolidated and parent-only figures mixed (right-hand column)

Selling, general and administrative expenses

  • Breakdown of selling, general and administrative expenses (costs of selling and running the company). Cost of sales not included
  • Each item: already inside the SG&A total (not added to it)

Finance

  • Net assets to total assets　Net assets ÷ total assets
  • Net assets per share　Parent only
  • Total assets　Parent only

Capital allocation

  • ★: position when all companies are sorted by value and cut into fifths (a position, not a rating). The five items with ★: only where both numerator and denominator are available on a consolidated basisSee the formulas
  • Cash conversion　Net cash provided by (used in) operating activities ÷ operating income

Long-term changes in performance

  • Revenue　Disclosed value for 2025 ÷ disclosed value for 2012

Year-on-year comparison

  • Year on year: calculated only where the item, reporting range and accounting standard match and the periods are consecutive
  • Comparison basis not confirmed: periods with a change of accounting standard or reporting range, a moved fiscal year end, or an unconfirmed period
  • ◆: a period where revenue moved 20% or more from the prior year, profit as a share of revenue moved 2.0 percentage points or more, or profit or loss changed sign. Item used named in the table and list. Not a ranking of companies

Earnings and net assets per share over time

  • Earnings per share = net profit ÷ shares; net assets per share = net assets ÷ shares. Disclosed values from the key financial indicators of the annual securities report. No share prices used

Return on equity over time

  • Return on equity (ROE): net profit as a proportion of equity. For Japanese companies, the disclosed value in the key financial indicators of the annual securities report (decimals converted to percentages)

Dividend history

  • Payout ratio: dividends as a proportion of net profit. Dividend amounts and payout ratios: the reporting company’s parent-only disclosed values (as written in the annual securities report, not recalculated from consolidated profit). Consecutive increases: years in a row, from the latest backwards, in which the annual dividend per share rose. Consecutive years with a dividend: years in a row with an annual dividend per share above zero. Both this site’s own count (not the criteria of any published index). A year with no disclosure not read as zero; counting stops there. Range limited to the years listed above. Flagged 4 years: a note about a stock split or share consolidation, or a period other than 12 months. No calculation across those years, as the dividend per share may rest on a different share base.

Share ownership by holder category

  • Source: ownership table, annual securities report. Percentages as disclosed, calculated on trading units (some companies do not total exactly 100%). Foreign holders (total): institutions and individuals combined. “Individuals and others”: a register category (not necessarily the share actually held by individuals). Industry median: the middle value among companies in Pharmaceuticals that disclose the item (industries with at least 5 companies only).

Major shareholders

  • Source: major shareholders table, annual securities report. Trust bank holdings as written (whose trust is not disclosed)

Research and development expenses and capital expenditure

  • Research and development: total in the R&D section of the annual securities report. Capital expenditure: this year’s actual spending in the capital expenditure overview (not a plan). Years: only those available in the annual securities reports on hand (one to four per company); no row for other years.

Revenue scale in the same industry

  • Revenue (disclosed values) of companies in the same industry, using the same grouping as the industry pages. Only the top three and the two companies either side of this one. Bar length relative to the largest company (100). An order of size, not a ranking of quality

Workforce information

  • All four: the reporting company (parent-only), as disclosed in the employee section of the annual securities report. Industry median: the middle value among companies in Pharmaceuticals that disclose the item (industries with at least 5 companies only).

People and organisation

  • Sales per employee　Net sales (or operating revenue) ÷ employees
  • Operating income per employee　Operating income ÷ employees
  • Wage gap between men and women　Women's pay with men's pay set to 100, reporting company
  • Women in managerial positions　Reporting company (parent only)
  • Average temporary staff　Parent only, average headcount other than regular employees

Workplace information filings

  • Source: processed from Shokuba-labo, the workplace information site of the Ministry of Health, Labour and Welfare. Items the company filed only Shokuba-labo

Subsidy award information

  • Source: gBizINFO (Ministry of Economy, Trade and Industry). Subsidy award records published by each ministry, matched by corporate number gBizINFO (METI)

Audit and disclosure information

  • Whether there is a going concern note (the accounting assumption that a company will continue operating), and audit information
  • Audit firm, audit fees, going concern note and accounting standard: facts written in the latest annual securities report and the audit report filed with it (not a judgement of the company). Going concern note: “note” when the note text is present, “not applicable” when the report states nothing to report, “cannot be determined” when neither appears. Note text not reproduced. Amended filings not shown (annual securities reports only)

Data sources and calculation methods

Primary source: the annual securities report of MIZUHO MEDY CO.,LTD. on EDINET, the FSA’s disclosure system (free to read)
Corporate number: 2300001006311 / Accounting standard: Japanese GAAP

  • Amounts: machine transcription of EDINET XBRL (no manual re-keying). Long narrative notes are text and not in the account list. Identifiers: machine transcription of the EDINET code list (retrieved 2026-08-22)
  • ★: position of the value calculated from disclosed figures among the 4,240 companies on this site, on a five-step scale. Not a judgement of the company. No forecasts usedThe formulas and how they are counted
  • No rank: net assets as a share of total assets, cash conversion and revenue per employee (size alone does not show quality). Industry median shown for comparison. Cash conversion of 100%: operating cash flow equal to operating profit
  • Profit-and-loss chart: only where “sales − cost of sales − SG&A = operating income” holds between disclosed values. Cost breakdown: the six largest SG&A items
  • Trend charts: key financial indicators of the annual securities report. Amounts in billions of yen (dividend per share in yen). Long-run chart joins reports filed in different years (newer report for overlapping years). Some items stop part-way after a change of accounting standard. A stock split changes the weight of one share. Consolidated and parent-only in separate tables
  • Revenue scale in the same industry: bars of revenue (disclosed values) of companies in the same industry grouping as the industry pages, largest first. Only the top three and the two companies either side of this one. Each company’s latest fiscal year. An order of size, not a ranking of quality or an investment view
  • Share prices: not published (no data source allows redistribution). No share-price-based indicators (such as the price earnings ratio) and no extension of past growth into the future
  • Average age, average length of service and average annual salary: the reporting company alone (the parent). At a holding company, a small head-office staff. Payout ratio (basic facts): dividend per share ÷ consolidated earnings per share, calculated here (the payout ratio in the annual securities report is the reporting company’s figure, on a different basis). Representative and founding date: gBizINFO (Ministry of Economy, Trade and Industry), some companies only
  • “Retrieved disclosed figures”: every value readable as a number from the annual securities report. Company-wide values only (no segment or other breakdowns)
  • Segment table: machine transcription of the segment information in the annual securities report. Business names as labelled by the company in its XBRL. No table where segment sales differ from the disclosed total by more than 1%. Adjustments, corporate, eliminations and “other” left out of the table and the share denominator, as they are not businesses
  • Breakdowns of amounts, not diagrams of how the business works. Who pays whom, and for what, is not in the disclosed figures; no lines drawn from guesswork